News and publications
Promethera Biosciences strengthens and completes its management team with two key senior appointments
Mont-Saint-Guibert, Belgium, 01 December, 2015 – Promethera Biosciences, a Belgian biotechnology company developing stem cell therapies for the treatment of inborn errors of metabolism and acquired liver diseases, today announces two senior appointments. Dr Jürgen Beck has been appointed as VP Clinical and Medical Affairs and Patrick Stragier as VP Operations.
PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01